Treatment of refractory pyoderma gangrenosum with infliximab in a 17-month-old boy.
This report details the case of a 17-month old boy with refractory multifocal pyoderma gangrenosum responsive to anti-TNF therapy.
Susan A
SA
Bobbitt
Ernst M
EM
Klaus
IWK Health Centre, Dalhousie University. Elizabeth.Stringer@iwk.nshealth.ca.
Elizabeth
E
Stringer
Dhiman
D
Chowdhury
Laura
L
Finlayson
D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000378:metabolism; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D000069285:Infliximab / Q000627:therapeutic use*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D017511:Pyoderma Gangrenosum / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D017211:Treatment Failure; D016896:Treatment Outcome
D003879:Dermatologic Agents; D005938:Glucocorticoids; D002097:C-Reactive Protein; D000069285:Infliximab; D008775:Methylprednisolone